Diversified Consumer Services
Company Overview of Cornell University
Cornell University is an educational institution that offers undergraduate majors, graduate, undergraduate and advanced degrees, and continuing education and outreach programs. It has seven undergraduate colleges; a graduate school; professional-degree schools in business management, medicine, law, and veterinary medicine; and affiliated faculty units. Cornell University was founded in 1865 and is based in Ithaca, New York.
144 East Avenue
Day Hall Lobby
Ithaca, NY 14850
Founded in 1865
Key Executives for Cornell University
Chief of Cornell University Police, Interim VP of Risk Mgmt & Public Safety and Assoc. VP
Natural Resource Team Coordinator
Director Emeritus of National Astronomy and Ionosphere Center (NAIC)
Senior Vice Provost - Research, VP for Technology Transfer, Intellectual Property & Research Policy
Director of Arecibo Observatory
Compensation as of Fiscal Year 2017.
Cornell University Key Developments
Cornell University Presents at Food and Nutrition Conference & Expo, Oct-21-2017
Oct 18 17
Cornell University Presents at Food and Nutrition Conference & Expo, Oct-21-2017 . Venue: Chicago, Illinois, United States. Speakers: Kathleen Rasmussen, the Nancy Schlegel Meinig Professor of Maternal and Child Nutrition, Marie Caudill, Professor, Patsy M Brannon, Professor.
Cornell University Presents at Strata + Hadoop World, Sep-26-2017 10:00 AM
Sep 23 17
Cornell University Presents at Strata + Hadoop World, Sep-26-2017 10:00 AM. Venue: Javits Convention Center, 655 W 34th Street, New York, New York, United States. Speakers: Madeleine Udell.
Recro Pharma, Inc. Enters into License Agreement with Cornell University
Jul 5 17
On June 30, 2017, Recro Pharma Inc. entered into a license agreement with Cornell University, pursuant to which Cornell granted the Company a worldwide, exclusive, sublicensable, royalty-bearing license in Cornell's patents and other intellectual property relating to an intermediate-acting neuromuscular blocking agent, a short-acting neuromuscular blocking agent and a reversal agent proprietary to the blocking agents (collectively, the Compounds), to develop, manufacture and sell the Compounds. Recro has agreed to develop, manufacture and sell the Compounds. The Agreement calls for Recro to follow a development plan included in the Agreement unless otherwise amended or agreed to by the parties. Under the terms of the Agreement, Recro is obligated to make: (i) an upfront payment in the amount of $350,000; (ii) an annual license maintenance fee payment until the first commercial sale of a Compound; and (iii) milestone payments upon the achievement of certain milestones, up to a maximum, for each neuromuscular blocking agent, of $5 million for U.S. regulatory approval and commercialization milestones and $3 million for European regulatory approval and comercialization milestones. Recro is also obligated to pay Cornell royalties on net sales of the Compounds at a rate ranging from low to mid single digits, depending on the applicable Compound and whether there is a valid patent claim in the applicable country, subject to an annual minimum royalty amount. In addition, Recro will reimburse Cornell for past and ongoing patent costs related to prosecution and maintenance of the patents related to the Compounds. The Agreement may be terminated (i) by Recro upon 90 days' written notice, (ii) by Cornell upon Recro's material breach, subject to a cure period, and (iii) immediately by Cornell if Recro files any claim asserting the invalidity of any of Cornell's patent rights related to the Compounds. The royalty term for each Compound expires, on a country-by-country basis, on the later of (i) the expiration date of the longest-lived licensed patent, (ii) the expiration of any granted statutory period of marketing exclusivity, or (iii) the first commercial sale of a generic equivalent of the applicable Compound. On the last to expire royalty term the Agreement will automatically convert to a royalty-free nonexclusive license.
Similar Private Companies By Industry
Recent Private Companies Transactions